While robot-assisted kidney transplantation (RAKT) offers potential benefits such as minimal postoperative pain, better cosmesis, fewer wound infections, and shorter hospital stay, its efficacy in ABO-incompatible (ABO-i) KT compared to open KT (OKT) remains understudied. This study aims to compare ABO-i KT outcomes between RAKT and OKT. The study utilized data from 29 ABO-i RAKT and 210 ABO-i OKT cases performed at Asan Medical Center from October 2020 to February 2023. Univariate and multivariate analyses were performed to evaluate factors associated with a composite of biopsy-proven acute rejection (BPAR), de novo donor-specific antibodies (DSA), and overall graft failure.
Study Type
OBSERVATIONAL
Enrollment
239
The interventional surgery is a robot-assisted kidney transplantation and its efficacy will be measured against that of open kidney transplantation
Asan Medical Center
Seoul, South Korea
Graft survival
allograft (kidney) survival
Time frame: 1 year post-operative
renal function
renal function measured in terms of eGFR (Estimated Glomerular Filtration Rate)
Time frame: 1 year post-operative
. A composite of biopsy-proven acute rejection, graft failure, and the development of de novo donor-specific antibodies
. A composite of biopsy-proven acute rejection, graft failure, and the development of de novo donor-specific antibodies
Time frame: 1 year post-operative
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.